{"title":"兴趣文章","authors":"Rick G. Smith","doi":"10.1051/ject/200537324","DOIUrl":null,"url":null,"abstract":"Eighty patients were entered in a randomized, doubleblinded, prospective trial to study the benefits of a new surface modification (SMARxT, Cobe Cardiovascular) on neurologic protection. Cardiotomy suction was avoided. Cerebral ischemia markers were similar in both groups but cognitive testing demonstrated a slight improvement in the coated circuit group. The authors warn that showing subtle, yet significant, improvements in clinical outcomes is difficult.","PeriodicalId":309024,"journal":{"name":"The Journal of ExtraCorporeal Technology","volume":"76 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2001-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Articles of Interest\",\"authors\":\"Rick G. Smith\",\"doi\":\"10.1051/ject/200537324\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Eighty patients were entered in a randomized, doubleblinded, prospective trial to study the benefits of a new surface modification (SMARxT, Cobe Cardiovascular) on neurologic protection. Cardiotomy suction was avoided. Cerebral ischemia markers were similar in both groups but cognitive testing demonstrated a slight improvement in the coated circuit group. The authors warn that showing subtle, yet significant, improvements in clinical outcomes is difficult.\",\"PeriodicalId\":309024,\"journal\":{\"name\":\"The Journal of ExtraCorporeal Technology\",\"volume\":\"76 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2001-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of ExtraCorporeal Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1051/ject/200537324\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of ExtraCorporeal Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1051/ject/200537324","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Eighty patients were entered in a randomized, doubleblinded, prospective trial to study the benefits of a new surface modification (SMARxT, Cobe Cardiovascular) on neurologic protection. Cardiotomy suction was avoided. Cerebral ischemia markers were similar in both groups but cognitive testing demonstrated a slight improvement in the coated circuit group. The authors warn that showing subtle, yet significant, improvements in clinical outcomes is difficult.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
